Oligonucleotides Targeted Against a Junction Oncogene Are Made Efficient by Nanotechnologies

Author： Maksimenko A.   Malvy C.   Lambert G.   Bertrand J-R.   Fattal E.   Maccario J.   Couvreur P.  

Publisher： Springer Publishing Company

ISSN： 0724-8741

Source： Pharmaceutical Research, Vol.20, Iss.10, 2003-10, pp. : 1565-1567

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oncogene-targeted antisense oligonucleotides for the treatment of Ewing sarcoma

By Maksimenko Andrei   Malvy Claude  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 4, 2005-08 ,pp. : 825-830

Informa Healthcare

Access to resources Recommend Favorite

Drugs targeted against protein kinases

By Kumar C Chandra   Madison Vincent  

Expert Opinion on Emerging Drugs, Vol. 6, Iss. 2, 2001-10 ,pp. : 303-315

Informa Healthcare

Access to resources Recommend Favorite

Importance of Receptor-targeted Systems in the Battle Against Atherosclerosis

By  

Current Pharmaceutical Design, Vol. 19, Iss. 33, 2013-10 ,pp. : 5897-5903

Bentham Science Publishers

Access to resources Recommend Favorite

Monitoring of antisense effects of oligonucleotides targeted to the neuropeptide Y Y 1 receptor gene

By Hanze J.   Worgall S.   Rascher W.  

European Journal of Pharmacology, Vol. 330, Iss. 1, 1997-07 ,pp. : 87-92

Elsevier

Access to resources Recommend Favorite

Receptors, endocytosis, and trafficking: the biological basis of targeted delivery of antisense and siRNA oligonucleotides

By Juliano R. L.   Carver K.   Cao C.   Ming X.  

Journal of Drug Targeting, Vol. 21, Iss. 1, 2013-01 ,pp. : 27-43

Informa Healthcare

Access to resources Recommend Favorite